Return On Assets in % of INTERCEPT PHARMACEUTICALS, INC. from Q2 2013 to Q3 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
INTERCEPT PHARMACEUTICALS, INC. quarterly/annual Return On Assets history and change rate from Q2 2013 to Q3 2023.
  • INTERCEPT PHARMACEUTICALS, INC. Return On Assets for the quarter ending 30 Sep 2023 was -12.7 %, a 132% decline year-over-year.
  • INTERCEPT PHARMACEUTICALS, INC. annual Return On Assets for 2022 was 42 %.
  • INTERCEPT PHARMACEUTICALS, INC. annual Return On Assets for 2021 was -17.5 %, a 60.7% increase from 2020.
  • INTERCEPT PHARMACEUTICALS, INC. annual Return On Assets for 2020 was -44.5 %, a 8.1% increase from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

INTERCEPT PHARMACEUTICALS, INC. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2023 -12.7 -52.3 -132% 01 Jul 2023 30 Sep 2023
Q2 2023 39.7 +52.3 01 Apr 2023 30 Jun 2023
Q1 2023 39.1 +52.3 01 Jan 2023 31 Mar 2023
Q4 2022 42 +59.4 01 Oct 2022 31 Dec 2022
Q3 2022 39.5 +59.5 01 Jul 2022 30 Sep 2022
Q2 2022 -12.6 +18.1 +58.9% 01 Apr 2022 30 Jun 2022
Q1 2022 -13.2 +25 +65.5% 01 Jan 2022 31 Mar 2022
Q4 2021 -17.5 +27 +60.7% 01 Oct 2021 31 Dec 2021
Q3 2021 -20 +28.5 +58.8% 01 Jul 2021 30 Sep 2021
Q2 2021 -30.7 +16.8 +35.3% 01 Apr 2021 30 Jun 2021
Q1 2021 -38.2 +7.05 +15.6% 01 Jan 2021 31 Mar 2021
Q4 2020 -44.5 +3.92 +8.1% 01 Oct 2020 31 Dec 2020
Q3 2020 -48.5 +2.91 +5.66% 01 Jul 2020 30 Sep 2020
Q2 2020 -47.5 +5.81 +10.9% 01 Apr 2020 30 Jun 2020
Q1 2020 -45.2 +15.1 +25% 01 Jan 2020 31 Mar 2020
Q4 2019 -48.4 +11.5 +19.2% 01 Oct 2019 31 Dec 2019
Q3 2019 -51.4 +13.8 +21.1% 01 Jul 2019 30 Sep 2019
Q2 2019 -53.3 +13.4 +20.1% 01 Apr 2019 30 Jun 2019
Q1 2019 -60.3 +8.25 +12% 01 Jan 2019 31 Mar 2019
Q4 2018 -59.9 +2 +3.23% 01 Oct 2018 31 Dec 2018
Q3 2018 -65.2 -8.04 -14.1% 01 Jul 2018 30 Sep 2018
Q2 2018 -66.7 -12.3 -22.7% 01 Apr 2018 30 Jun 2018
Q1 2018 -68.5 -13.7 -25% 01 Jan 2018 31 Mar 2018
Q4 2017 -61.9 -0.04 -0.07% 01 Oct 2017 31 Dec 2017
Q3 2017 -57.2 +1.79 +3.04% 01 Jul 2017 30 Sep 2017
Q2 2017 -54.4 +0.75 +1.36% 01 Apr 2017 30 Jun 2017
Q1 2017 -54.8 -8.69 -18.8% 01 Jan 2017 31 Mar 2017
Q4 2016 -61.9 -26.3 -74% 01 Oct 2016 31 Dec 2016
Q3 2016 -59 -26.7 -82.8% 01 Jul 2016 30 Sep 2016
Q2 2016 -55.1 -18.3 -49.7% 01 Apr 2016 30 Jun 2016
Q1 2016 -46.1 -22.1 -91.7% 01 Jan 2016 31 Mar 2016
Q4 2015 -35.6 +78.6 +68.8% 01 Oct 2015 31 Dec 2015
Q3 2015 -32.2 +85.1 +72.5% 01 Jul 2015 30 Sep 2015
Q2 2015 -36.8 +97.9 +72.7% 01 Apr 2015 30 Jun 2015
Q1 2015 -24.1 +173 +87.8% 01 Jan 2015 31 Mar 2015
Q4 2014 -114 -67.3 -144% 01 Oct 2014 31 Dec 2014
Q3 2014 -117 -53.7 -84.3% 01 Jul 2014 30 Sep 2014
Q2 2014 -135 -78.1 -138% 01 Apr 2014 30 Jun 2014
Q1 2014 -197 01 Jan 2014 31 Mar 2014
Q4 2013 -46.8 01 Oct 2013 31 Dec 2013
Q3 2013 -63.7 01 Jul 2013 30 Sep 2013
Q2 2013 -56.6 01 Apr 2013 30 Jun 2013

INTERCEPT PHARMACEUTICALS, INC. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2022 42 +59.4 01 Jan 2022 31 Dec 2022
2021 -17.5 +27 +60.7% 01 Jan 2021 31 Dec 2021
2020 -44.5 +3.92 +8.1% 01 Jan 2020 31 Dec 2020
2019 -48.4 +11.5 +19.2% 01 Jan 2019 31 Dec 2019
2018 -59.9 +2 +3.23% 01 Jan 2018 31 Dec 2018
2017 -61.9 -0.04 -0.07% 01 Jan 2017 31 Dec 2017
2016 -61.9 -26.3 -74% 01 Jan 2016 31 Dec 2016
2015 -35.6 +78.6 +68.8% 01 Jan 2015 31 Dec 2015
2014 -114 -67.3 -144% 01 Jan 2014 31 Dec 2014
2013 -46.8 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.